Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ICAS Acquires NHS-Commissioned Mental Health Startup Hello Tomo, Targets $121B Mental Health Market
While the global coronavirus pandemic affected mental health around the world — ICAS World Ltd […]
AskBio Announces IND for LION-101 Cleared to Proceed by U.S. FDA
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that […]
Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US
Prosit Sole Biotechnology, a clinical-stage biotech company developing novel protein therapeutics, today announces that it […]
UK Vivan Therapeutics Secures Expanded Drug Discovery & Development Platform From Mount Sinai Health System in New York
My Personal Therapeutics Ltd. (trading as Vivan Therapeutics), a UK-based company, announces an expansion of […]
Study into Whether Vaccination of Previously Infected Generates Stronger, Broader Coronavirus Antibody Response
NHS Blood and Transplant (NHSBT) is carrying out a study in the Birmingham region aimed […]
VeriFLY ™ Now First Digital Wallet To Accept Vaccine Health Credential Around The World
VeriFLY ™, the world’s first widely adopted digital wallet created to help travelers and event […]
Inequalities in Disability Between Richest and Poorest in the UK More than Tripled in past Decades, New ILC Report Finds
A new report published today by the International Longevity Centre UK (ILC), drawing on a […]
Curebase Unlocks Drug Development with Remote Clinical Trials; Raises $15m Led by GGV Capital
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial […]
InterSystems and Oncodesign Partner for the Optimization of Data Use to Enhance and Accelerate Drug Discovery Processes in Oncologyery Processes in Oncology
InterSystems, a leader in healthcare data management, and Oncodesign (Paris:ALONC), a biopharmaceutical company specializing in precision medicine, […]
European Commission Approves Venclyxto-based Combinations for Adults with Newly Diagnosed Acute Myeloid Leukaemia Who Are Ineligible for Intensive Chemotherapy
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Venclyxto […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more